Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act

Tanja R Zijp; Martha L Toren-Wielema; Prashant V Nannan Panday; Jos G W Kosterink; Stefan P Berger; Daan J Touw

doi:10.1097/FTD.0000000000000766

Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act

Tanja R Zijp, Martha L Toren-Wielema, Prashant V Nannan Panday, Jos G W Kosterink, Stefan P Berger, Daan J Touw^*

^*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

7 Citaten (Scopus)

123 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	652-653
Aantal pagina's	2
Tijdschrift	Therapeutic Drug Monitoring
Volume	42
Nummer van het tijdschrift	4
Vroegere onlinedatum	2020
DOI's	https://doi.org/10.1097/FTD.0000000000000766
Status	Published - 1-aug.-2020

Toegang tot document

10.1097/FTD.0000000000000766Licentie: CC BY-NC-ND

Important_Interactions_of_Immunosuppressants_With.21Final publisher's version, 95,7 KBLicentie: CC BY-NC-ND

Handle.net

Permanente koppeling

Citeer dit

@article{9ee1ef6899b8494bb3b0d04b2c6a2ed4,

title = "Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act",

author = "Zijp, {Tanja R} and Toren-Wielema, {Martha L} and {Nannan Panday}, {Prashant V} and Kosterink, {Jos G W} and Berger, {Stefan P} and Touw, {Daan J}",

year = "2020",

month = aug,

day = "1",

doi = "10.1097/FTD.0000000000000766",

language = "English",

volume = "42",

pages = "652--653",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "4",

}

TY - JOUR

T1 - Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19)

T2 - how to act

AU - Zijp, Tanja R

AU - Toren-Wielema, Martha L

AU - Nannan Panday, Prashant V

AU - Kosterink, Jos G W

AU - Berger, Stefan P

AU - Touw, Daan J

PY - 2020/8/1

Y1 - 2020/8/1

U2 - 10.1097/FTD.0000000000000766

DO - 10.1097/FTD.0000000000000766

M3 - Comment/Letter to the editor

C2 - 32433189

SN - 0163-4356

VL - 42

SP - 652

EP - 653

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 4

ER -